NeRRe Therapeutics (AgeTech UK) Medical
Neurokinin treatment for refractory and/or chronic cough. NeRRe Therapeutics is a clinical-stage company developing a unique pipeline of three neurokinin -1 receptor antagonists (NK-1RAs) for the treatment of common, chronic and debilitating conditions caused by neural hypersensitivity associated with Substance P/ NK-1 receptor system dysfunction. Their focus with NeRRe’s lead NK-1 antagonist orvepitant is on Refractory or Unexplained Chronic Cough (RUCC).
Technology:
AgeTech Companies
Industry:
UK AgeTech 2020
Headquarters:
United Kingdom
Founded Date:
N/A
Employees Number:
N/A
Funding Status:
N/A
Register and Claim Ownership